NCT07432789

Brief Summary

Cerebral palsy is a common neurological disorder that is the leading cause of motor disability in children. It causes significant motor impairments, affecting various aspects such as fine and gross motor skills, as well as locomotion, which has a major impact on the quality of life of affected children. It is therefore essential to characterize these functional impairments in order to guide clinical decisions and maximize the motor function of affected children. Currently, the assessment of motor function is based on physical examinations and functional scales, such as the Gross Motor Function Classification System, which is specifically designed to assess children with CP. However, movement analysis using optoelectronic systems is considered the gold standard for this assessment, even though these systems have notable limitations (expensive installation, time-consuming use, and use only in a clinical environment, making it difficult to assess motor skills in children's everyday lives). In order to establish a comprehensive and personalized functional diagnosis, it is crucial to evaluate other fundamental motor tasks such as running, jumping, object control, and balance tasks. Recently, innovative markerless motion analysis technologies have been developed that allow analysis using smartphones or tablets outside of healthcare facilities. Therefore, developing an application dedicated to motion analysis for children with cerebral palsy that is easy to access and can be used frequently could yield many significant benefits.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
30mo left

Started Mar 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress7%
Mar 2026Nov 2028

First Submitted

Initial submission to the registry

February 10, 2026

Completed
15 days until next milestone

First Posted

Study publicly available on registry

February 25, 2026

Completed
21 days until next milestone

Study Start

First participant enrolled

March 18, 2026

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 16, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 16, 2028

Last Updated

April 17, 2026

Status Verified

April 1, 2026

Enrollment Period

2.7 years

First QC Date

February 10, 2026

Last Update Submit

April 14, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Angle (in degrees) of knee flexion in sagittal view during a two-foot vertical jump using digital motion analysis software

    We will measure the left and right knees, which will be classified as either the most affected lower limb or the least affected lower limb in the PC group.

    Up to 8 months

  • Angle (in degrees) of knee flexion in sagittal view during a two-foot vertical jump using the Gold Standard system (Motion Capture System).

    We will measure the left and right knees, which will be classified as either the most affected lower limb or the least affected lower limb in the PC group.

    Up to 8 months

Study Arms (2)

Children with a medical diagnosis of cerebral palsy as defined by SCPE

EXPERIMENTAL
Other: Assessment of functional abilitiesOther: Children's self-questionnairesOther: Parent self-assessment questionnairesOther: Semi-structured interview

Healthy volunteers

ACTIVE COMPARATOR
Other: Assessment of functional abilities

Interventions

ABILOCO-Kids

Children with a medical diagnosis of cerebral palsy as defined by SCPE

GOAL

Children with a medical diagnosis of cerebral palsy as defined by SCPE

Interview

Children with a medical diagnosis of cerebral palsy as defined by SCPE

Gold standard

Children with a medical diagnosis of cerebral palsy as defined by SCPEHealthy volunteers

Eligibility Criteria

Age6 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Common to both groups:
  • Obtaining free and informed consent from the child and at least one parent
  • Children of all genders aged 6 to 18
  • Children affiliated with or beneficiaries of a social security system
  • For the Cerebral Palsy group:
  • Medical diagnosis of CP according to the SCPE (Surveillance of Cerebral Palsy in Europe) definition;
  • Unilateral and bilateral impairment;
  • Gross Motor Function Classification System (GMFCS) = I to III;
  • No major cognitive or visual impairments that limit the performance of motor tasks
  • For the control group:
  • \- Children free from any disease
  • Other volunteers included in the protocol (qualitative analysis only (parents and clinicians)):
  • Parent(s) of children with CP included in this study;
  • Healthcare professionals and researchers involved in monitoring children with CP and/or evaluating the research application within the framework of this study

You may not qualify if:

  • Common to both groups:
  • Participants or parent(s) of participants who do not speak French
  • Children subject to legal protection measures
  • Pregnant or breastfeeding participants
  • For the Cerebral Palsy group:
  • Presence of a cause of neuro-orthopedic disorders other than CP
  • Limiting pain
  • Medical or surgical interventions planned between visit 1 and visit 2
  • Children with a condition other than cerebral palsy that affects their walking ability

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chu Dijon Bourgogne

Dijon, 21000, France

RECRUITING

MeSH Terms

Conditions

Cerebral Palsy

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 10, 2026

First Posted

February 25, 2026

Study Start

March 18, 2026

Primary Completion (Estimated)

November 16, 2028

Study Completion (Estimated)

November 16, 2028

Last Updated

April 17, 2026

Record last verified: 2026-04

Locations